Imon is an investment analyst and journalist with an enthusiasm for financial research and writing. She began her career at Kantar IMRB, a leading market research and consumer consulting organization.
Imon studied St. Xavier's University, where she majored in Economics and wrote her academic thesis on inflation and the stock market.
Leading luxury items reseller RealReal (REAL) recently saw its shares get crushed despite reporting strong revenue and GMV growth in the first quarter. The company’s wider-than-expected losses and rising competition in the luxury resale market make its growth prospects gloomy. Also, given that REAL hasn't yet been able to improve its profitability, will the stock be able to recover? Read ahead to learn more. May 23, 2022| 9:24am
Currently trading at $1.54, popular mobile e-commerce platform ContextLogic (WISH) has seen its shares tumble in price over the past month on investor pessimism surrounding the company’s unimpressive first-quarter performance. And given that WISH continues to grapple with multiple near-term headwinds, is it worth betting on the stock at its current price level? Let’s find out. May 16, 2022| 8:38am
Shares of leading insurance provider Allstate Corporation (ALL) have dipped in price recently as inflation continues to weigh heavy on its financials. Although the company has seen higher growth in premiums due to policy growth, given that increases in claim severity in a higher interest rate and a higher inflation rate environment could hurt its profitability, is it worth betting on the stock now? Let’s find out. May 16, 2022| 8:17am
Leading global REIT American Tower (AMT) has made significant advancements in expanding its communications real estate footprint to capitalize on rapid 5G deployment in the U.S. and Europe. However, given that interest rate fears and a heavy debt load could weigh heavily on its stock price, will AMT be able to maintain its market standing? Read on. Here’s what we think. May 9, 2022| 8:07am
Shares of money transfer services provider Western Union (WU) have tumbled recently on the back of a broader market dip and concerns surrounding the halt of its operations in Russia and Belarus. Although strategic partnerships could help expand its global network significantly, a decline in retail money transfers and expenses related to the recent divestiture of its Business Solutions segment could mar its growth. So, can the stock recover from its recent price dip? Read on to learn our view. May 9, 2022| 7:49am
Coal mining company Peabody Energy (BTU) saw its shares shoot up year-to-date, driven by skyrocketing coal prices amid the Russia-Ukraine conflict and many nations planning to ban coal imports from Russia. Given that the demand for coal continues to rise due to surging electricity consumption and a natural gas shortage, can the coal producer continue to maintain its momentum? Let’s discuss. May 2, 2022| 9:56am
International oil and gas company Exxon Mobil Corporation’s (XOM) huge profit increases in the first quarter of 2022, driven by lofty crude oil prices and the strength of its growing production portfolio positions, should help it see strong growth in the near term. Given that the oil giant continues to make advancements in low-emission opportunities, is it poised to outperform this year? Let’s discuss. May 2, 2022| 9:54am
Hydrogen fuel cell technology company Ballard Power Systems (BLDP) has made significant advances as a leading fuel cell player in the medium- and heavy-duty mobility markets. But even though BLDP stock is currently trading at less than $10, given the company’s weak margins and the fact that it is struggling to generate more revenues from its Technology Solutions segment, is it worth betting on the stock now? Let’s find out. Read on. Apr 25, 2022| 7:48am
Shares of the leading provider of title insurance, Fidelity National Financial (FNF), have slipped 17.1% in price over the past month as investors remain worried about a potential housing bubble. While accelerating commercial and residential purchases have boosted the company’s revenues, can its shares recover in the near term, given the concerns surrounding its declining refinance volumes amid rising inflation? Read more to learn our view. Apr 25, 2022| 7:29am
Leading pharmaceutical retailer Rite Aid (RAD) shares jumped last week thanks to its stronger-than-expected fourth-quarter revenue growth driven by an increase in same-store and pharmacy sales. Although the company’s strategic initiatives to boost membership should bode well for the stock, its struggling Elixir business and expanding losses could lead to negative sentiment. So, is it worth investing in now? Apr 18, 2022| 2:17pm